Molecular Prognosis of Cardiogenic Shock Patients under Extracorporeal Membrane Oxygenation

Prognosis for cardiogenic shock patients under ECMO was our study goal. Success defined as survived more than 7 days after ECMO installation and failure died or had multiple organ failure in 7 days. Total 34 cases were enrolled, 17 success and 17 failure. Peripheral blood mononuclear cells collected at ECMO installation were used analyzed. Analysis of the cardiogenic shock patients at extracorporeal membrane oxygenation treatment by genome-wide expression and methylation. Transcriptomic profiling and DNA methylation between successful and failure groups were analyzed. This submission represents the transcriptome data.